DeepMed Research

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

GSK-1521498

Generic Name: GSK-1521498

Drug Type: Small Molecule

Chemical Formula: C_₂₄H_₂₀F_₂N_₄

CAS Number: 1007573-18-3

Unique Ingredient Identifier: W0UTB622GK

Overview

GSK1521498 has been used in trials studying the treatment of Obesity and Alcoholism.

Background

GSK1521498 has been used in trials studying the treatment of Obesity and Alcoholism.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

To Evaluate the Influence of the A118G Polymorphism in the mu Opioid Receptor Gene (OPRM1) on Effects of GSK1521498 and Naltrexone on Physiological and Behavioural Markers of Brain Function in Healthy Social Drinkers

Phase 1

Completed

Posted: 2012/11/30

Sponsor:GlaxoSmithKline

GSK1521498 Alcohol Interaction Study

Phase 1

Completed

Posted: 2011/06/06

Sponsor:GlaxoSmithKline

A 35 Day Study to Investigate the Effects of GSK1521498 on Bodyweight in Obese Subjects With Over-Eating Behaviours.

Phase 2

Completed

Posted: 2010/09/06

Sponsor:GlaxoSmithKline

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy